Ning-yu X. Wang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Design, synthesis and biological evaluation of novel 9-methyl-9H-purine and thieno[3, 2-d]pyrimidine derivatives as potent mTOR inhibitors.
Journal: Bioorganic chemistry
Published: September 11, 2022
Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor.
Journal: European journal of medicinal chemistry
Published: August 17, 2021
Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma.
Journal: Bioorganic chemistry
Published: June 21, 2020
Design, synthesis and structure-activity relationship study of piperazinone-containing thieno[3,2-d]pyrimidine derivatives as new PI3Kδ inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: April 21, 2020
Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
Journal: Cell death & disease
Published: September 28, 2019
Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.
Journal: European journal of medicinal chemistry
Published: July 25, 2019
Design, synthesis and biological evaluation of 3,5-dimethylisoxazole and pyridone derivatives as BRD4 inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: April 21, 2019
Author Correction: Structural and functional studies on Pseudomonas aeruginosa DspI: implications for its role in DSF biosynthesis.
Journal: Scientific reports
Published: August 18, 2018
Structural characterization of a Δ3, Δ2-enoyl-CoA isomerase from Pseudomonas aeruginosa: implications for its involvement in unsaturated fatty acid metabolism.
Journal: Journal of biomolecular structure & dynamics
Published: July 28, 2018
Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles.
Journal: RSC advances
Published: January 24, 2018
Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.
Journal: Antimicrobial agents and chemotherapy
Published: November 19, 2017
Last Updated: 09/26/2026